The Israel Institute of Biological Research has isolated the key COVID-19 antibody. The “monoclonal neutralizing antibody” developed by the institute is reported to neutralize COVID-19 virus inside the infected person.
Highlights
- The scientists believe that the antibody can possibly be the antidote that can be used in the treatment of COVID-19.
- The antibody is called monoclonal as it was isolated from a single recovered cell.
- The monoclonal antibodies have greater potent values in treating the disease.
- Till now, the antibodies that have been isolated are polyclonal. Polyclonal is isolating anti bodies from several recovered cells.
- This is the first time, the antibodies of COVID-19 are isolated from monoclonal antibodies.
Background
- Israel so far has 16,246 COVID-19 cases.
- This includes 235 fatalities and 10,064 recoveries.
- It was one of the first countries to close international borders.
Antibodies
- Antibodies are proteins naturally produced in human bodies in order to respond the foreign particles that invade human bodies.
- The antibodies are specific to the invader.
- The concept is used to test COVID-19 as well.
Antibody Test of COVID-19
- The antibodies present in blood samples of a person indicate that at some point of time he was exposed to the virus.
- This concept is used to detect the presence of the virus.
- India has adopted rapid anti body testing for surveillance purpose.
- However, it is still using RT-PCR to confirm the virus.
- The RT-PCR takes 4 to 5 hours to produce results.
No comments:
Post a Comment